Sigilon Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Sigilon Therapeutics

11/05/2021 04:09

* Sigilon Therapeutics Inc  SGTX.OQ  reported a quarterly
adjusted loss of 60 cents​​ per share for the quarter ended
in March. The mean expectation of three analysts for the quarter
was for a loss of 59 cents per share.
* Revenue was $2.96 million​​;  analysts expected $3.50 million.
* Sigilon Therapeutics Inc's reported EPS for the quarter was a
loss of 60 cents​.
* The mean earnings estimate of analysts had fallen by
about 2.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Sigilon Therapeutics Inc shares had fallen by 40.5% this
quarter and lost 72.3% so far this year.
* The company reported a quarterly loss of $18.97 million.
* Wall Street's median 12-month price target for Sigilon
Therapeutics Inc is $47.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 03:08 a.m. GMT.
​All figures in $